Jiang Yanchao, Zhang Ting, Kusumanchi Praveen, Han Sen, Yang Zhihong, Liangpunsakul Suthat
Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Roudebush Veterans Administration Medical Center, Indianapolis, IN 46202, USA.
Biomedicines. 2020 Mar 4;8(3):50. doi: 10.3390/biomedicines8030050.
Once ingested, most of the alcohol is metabolized in the liver by alcohol dehydrogenase to acetaldehyde. Two additional pathways of acetaldehyde generation are by microsomal ethanol oxidizing system (cytochrome P450 2E1) and catalase Acetaldehyde can form adducts which can interfere with cellular function, leading to alcohol-induced liver injury. The variants of alcohol metabolizing genes encode enzymes with varied kinetic properties and result in the different rate of alcohol elimination and acetaldehyde generation. Allelic variants of these genes with higher enzymatic activity are believed to be able to modify susceptibility to alcohol-induced liver injury; however, the human studies on the association of these variants and alcohol-associated liver disease are inconclusive. In addition to acetaldehyde, the shift in the redox state during alcohol elimination may also link to other pathways resulting in activation of downstream signaling leading to liver injury.
一旦摄入,大部分酒精在肝脏中通过乙醇脱氢酶代谢为乙醛。乙醛生成的另外两条途径是通过微粒体乙醇氧化系统(细胞色素P450 2E1)和过氧化氢酶。乙醛可形成加合物,干扰细胞功能,导致酒精性肝损伤。酒精代谢基因的变体编码具有不同动力学特性的酶,导致酒精消除和乙醛生成的速率不同。这些具有较高酶活性的基因的等位基因变体被认为能够改变对酒精性肝损伤的易感性;然而,关于这些变体与酒精相关性肝病关联的人体研究尚无定论。除了乙醛,酒精消除过程中氧化还原状态的变化也可能与其他途径相关,导致下游信号激活,进而导致肝损伤。